Home / Data / Recall & Adverse Event Monitor Recall & Adverse Event Monitor Recall & Adverse Event Monitor organizes records from openFDA API into a static ledger for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 2,000
Last changed 08/30/2026
Update schedule 28 2 * * 4 UTC
Coverage 06/30/2026–06/30/2026 2026-06-30
Title CYCLOPHOSPHAMIDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title KENALOG
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title COBENFY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VABYSMO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TECLISTAMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title LENALIDOMIDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title FINTEPLA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ROSUVASTATIN CALCIUM
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title CYCLOPHOSPHAMIDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title IMAAVY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title CYCLOPHOSPHAMIDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DALVANCE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title AIMOVIG
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title QINLOCK
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ATORVASTATIN CALCIUM\EZETIMIBE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VYLEESI
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TISLELIZUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ADALIMUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title YIMMUGO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VOLTAREN ARTHRITIS PAIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title HYDROXYZINE HYDROCHLORIDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title LINEZOLID
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NUCALA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TARLATAMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title REPATHA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SATRALIZUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VABYSMO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OXCARBAZEPINE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24 Source U.S. Food and Drug Administration, openFDA API · official record · retrieved 08/30/2026 · upstream last modified 08/30/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. Food and Drug Administration
Required notice Reports do not prove causation and are not medical advice, diagnosis, or an assessment of individual risk. What we add We compute Event Classification, Age Or Deadline Days, Public Significance Score using the documented compute method. · methodology